Neurological Disease
-
Neurological Disease Related Products (19215)
Related Products (19215)
-
Antibodies (42)
-
Related Compound Screening Libraries (7)
-
ZSET-845
0 ImagesCat. No.: HY-U00114CAS No.: 324077-62-5ZSET-845 is a cognitive enhancer which enhances choline acetyltransferase activity in the hippocampus in the rat.
-
Neuromuscular Disorder-Targeting Compound 1
0 ImagesCat. No.: HY-U00385CAS No.: 374538-23-5Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome.
-
Verilopam
0 ImagesCat. No.: HY-U00338CAS No.: 68318-20-7Verilopam is a potent analgesic.
-
Sch412348
0 ImagesCat. No.: HY-U00189CAS No.: 377727-26-9
-
Urinary Incontinence-Targeting Compound 1
0 ImagesCat. No.: HY-U00357CAS No.: 137315-05-0Urinary Incontinence-Targeting Compound 1 is a sulfonanilide derivative, used in the research of urinary incontinence.
-
2: PN: US20040072744 SEQID: 2 claimed protein
0 ImagesCat. No.: HY-U00372CAS No.: 389572-87-62: PN: US20040072744 SEQID: 2 claimed protein is a synthetic peptide, used for the research of Down's syndrome and schizophrenia.
-
α2δ ligand 1
0 ImagesCat. No.: HY-U00388CAS No.: 313653-15-5α2δ ligand 1 is a ligand to the α2δ-1 subunit of voltage-sensitive calcium channel, extracted from patent US20040186177.
-
Zatosetron maleate
0 ImagesCat. No.: HY-U00234CAS No.: 123482-23-5Synonyms: LY 277359 maleateZatosetron maleate is a potent and selective 5HT3 receptor antagonist.
-
CGP11952
0 ImagesCat. No.: HY-U00192CAS No.: 64078-09-7CGP11952 is a triazolyl-Benzaphenon resembling the benzodiazepines in its pharmacological action. CGP11952 is an experimental benzodiazepine derivative.
-
Anticonvulsant agent 1
0 ImagesCat. No.: HY-U00348CAS No.: 357336-17-5Synonyms: 4-(2,2-Difluoroethenyl)-α-ethyl-2-oxo-1-pyrrolidineacetamideAnticonvulsant agent 1 is an anticonvulsant agent extracted from patent WO2001062726A2, Compound 156.
-
Oiligodendrocyte differentiation promoter 1
0 ImagesCat. No.: HY-U00394CAS No.: 400760-25-0Oiligodendrocyte differentiation promoter 1 belongs to the oiligodendrocyte differentiation promoter.
-
Darodipine
0 ImagesCat. No.: HY-U00086CAS No.: 72803-02-2Synonyms: PY 108-068; PY-108068Darodipine (PY 108-068, PY-108068) is a potent calcium channel antagonist.
-
U91356
0 ImagesCat. No.: HY-U00227CAS No.: 152886-85-6U91356 is a dopamine receptor agonist.
-
CDD0102
0 ImagesCat. No.: HY-U00230CAS No.: 146422-58-4Synonyms: CDD0102ACDD0102 is a potent M1 Muscarinic receptor agonist.
-
Neurodegenerative Disorder-Targeting Compound 1
0 ImagesCat. No.: HY-U00362CAS No.: 1254698-39-9Neurodegenerative Disorder-Targeting Compound 1 is a calpain inhibitor extracted from patent WO2010128102A1, compound example 63.
-
Tachykinin angatonist 1
0 ImagesCat. No.: HY-U00392CAS No.: 178310-77-5Tachykinin angatonist 1 is a neurokinin receptor antagonist extracted from patent US5968923, compound example 32.
-
Sch59498
0 ImagesCat. No.: HY-U00374CAS No.: 224157-99-7Sch59498 is a potent inhibitor of phosphodiesterase 1c (Pde1c).
-
Anti-neurodegeneration agent 1
0 ImagesCat. No.: HY-U00314CAS No.: 289893-23-8Anti-neurodegeneration agent 1 a neurodegeneration-targeting compound extracted from patent WO2008039514A1, Compound I.
-
(5R)-BW-4030W92
0 ImagesCat. No.: HY-19282ACAS No.: 189013-61-4(5R)-BW-4030W92 is the R enantiomer of BW-4030W92. BW-4030W92 is a non-selective, voltage-, and use-dependent sodium channel antagonist.
